• News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in allergan

Glenmark Stock Up After US Approval To Its Savella Generic

Shares of drug maker Glenmark Pharmaceuticals rose 0.52 per cent to Rs 868. 45 a unit on BSE on Friday, a day that saw the benchmark Sensex down by at least 50 points

Read More

Dr Reddy's To Buy Eight Products In US For $350 Million

The portfolio consists of products that are being divested by Teva as a precondition to its closing of the acquisition of Allergan's generics business, the Hyderabad-based firm said

Read More

Investors Stick With Pfizer CEO After Allergan Deal Collapse

In 2014, Pfizer failed in its unsolicited $118 billion bid to buy London-based drugmaker AstraZeneca Plc after that deal ran into staunch opposition from British politicians

Read More

Obama's Inversion Curbs Kill Pfizer's $160 Billion Allergan Deal

Pfizer will have to pay Allergan up to $400 million for its expenses as a result of terminating the deal, according to their merger agreement

Read More

Teva Set To Win EU Okay For $40.5 Billion Allergan Deal

Teva will gain bigger economies of scale, a crucial element in the low-margin generic drugs business, with the deal, the largest in Israel's corporate history.

Read More

Pfizer Set To Buy Allergan For $150 Billion To Create World's Biggest Drug Maker

The deal is sure to draw political ire in a US presidential election year because Pfizer would redomicile to Ireland, where Allergan is registered, in a so-called 'inversion' that would slash its corporate tax rate

Read More

Pfizer-Allergan Talks Accelerate Amid New Inversion Clamp-down

Pfizer is negotiating a price of $370 to $380 for each Allergan share. Allergan shares ended trading on Wednesday at $310.8 per share

Read More